10x Genomics, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-62.34
Forward P/E Ratio
133.98
PEG Ratio
0.92
-37.66
Price-to-Sales (TTM)
4.44
3.58
6.24
Market Cap
2.79B
2.41B
Is it profitable?
Net Profit Margin (TTM)
-6.77%
Gross Profit Margin
68.09%
Diluted EPS (TTM)
-0.35
-5.78%
642.82M
Is it growing?
0.60%
0.61%
Is it risky?
2.17
10.59
4.46
84.36M
Who owns it?
107.97%
1.84%
19.56%
127.69M
115.30M
Does it pay?
0.00%
0.00%
--
--
How much cash?
523.41M
136.05M
148.39M
4.10
- Price
- 23.02
- Percent Change
- +1.20 (5.50%)
- Previous Close
- 21.82
- Open
- 23.38
- Low
- 22.45
- High
- 23.62
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$23.02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11.71
3M
$20.46
1M
$20.91
Today
$23.02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11.71
3M
$20.46
1M
$20.91
Today
$23.02
Expensive
within its 1-year price range
$23.02
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+10.1%
3M
+12.5%
6M
+96.6%
1Y
+165.5%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- Jan 1, 2012
- Founders
- Dr. Serge Saxonov Ph.D., Ben Hindson, Kevin Ness
- CEO
- Serge Saxonov
- Employees
- 1,306
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Indicators
Operating Cash Flow
136.05M
Net Income
-43.54M
Warning Sign
-3.12
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
136.05M
Net Income
-43.54M
Warning Sign
-3.12
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-62.34
Forward P/E Ratio
133.98
PEG Ratio
0.92
-37.66
Price-to-Sales (TTM)
4.44
3.58
6.24
Market Cap
2.79B
2.41B
Is it profitable?
Net Profit Margin (TTM)
-6.77%
Gross Profit Margin
68.09%
Diluted EPS (TTM)
-0.35
-5.78%
642.82M
Is it growing?
0.60%
0.61%
Is it risky?
2.17
10.59
4.46
84.36M
Who owns it?
107.97%
1.84%
19.56%
127.69M
115.30M
Does it pay?
0.00%
0.00%
--
--
How much cash?
523.41M
136.05M
148.39M
4.10
- Price
- 23.02
- Percent Change
- +1.20 (5.50%)
- Previous Close
- 21.82
- Open
- 23.38
- Low
- 22.45
- High
- 23.62
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$23.02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11.71
3M
$20.46
1M
$20.91
Today
$23.02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11.71
3M
$20.46
1M
$20.91
Today
$23.02
Expensive
within its 1-year price range
$23.02
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+10.1%
3M
+12.5%
6M
+96.6%
1Y
+165.5%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- Jan 1, 2012
- Founders
- Dr. Serge Saxonov Ph.D., Ben Hindson, Kevin Ness
- CEO
- Serge Saxonov
- Employees
- 1,306
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com